Download CSUSM NURS 316A EXAM 1 PATHOPHYSIOLOGY & PHARMACOLOGY FOR ACCELERATED BSN STUDY GUIDE and more Exams Pathophysiology in PDF only on Docsity!
CSUSM NURS 316A EXAM 1 PATHOPHYSIOLOGY &
PHARMACOLOGY FOR ACCELERATED BSN STUDY GUIDE
ALL VERIFIED QUESTIONS, ANSWERS & RATIONALES
This premium study guide delivers highly specialized multiple- choice practice questions with detailed diagnostic rationales for the NURS 316A curriculum. It seamlessly integrates foundational pathophysiology concepts like cellular adaptation and acid-base mechanics with essential pharmacokinetic principles to ensure complete mastery of Exam 1 material. Optimized specifically for fast-paced accelerated nursing students, this resource acts as a high-yield tool to secure top- tier marks on challenging assessments.
1. A patient presents with a plasma pH of 7.21 and a PaCO of 58 mmHg. Which intervention is most appropriate to correct this underlying imbalance? A. Intravenous administration of sodium bicarbonate B. Administration of albuterol via nebulizer C. Insertion of a nasogastric tube to low intermittent suction D. Initiation of an insulin infusion pump Answer: B Rationale: A pH of 7.21 with an elevated PaCO2 indicates respiratory acidosis. Respiratory acidosis is caused by hypoventilation and carbon dioxide retention. Administering a bronchodilator like albuterol helps open
the airways, improve alveolar ventilation, and clear trapped carbon dioxide, addressing the root cause.
2. The nurse evaluates an elevated anion gap on a comprehensive metabolic panel. This diagnostic value is primarily utilized to differentiate the underlying causes of which acid-base disturbance? A. Respiratory Acidosis B. Respiratory Alkalosis C. Metabolic Acidosis D. Metabolic Alkalosis Answer: C Rationale: The anion gap measures the difference between measured cations and unmeasured anions in the serum. It is specifically calculated during states of metabolic acidosis to determine whether the acidosis is caused by an accumulation of metabolic acids (high anion gap, e.g., diabetic ketoacidosis, lactic acidosis) or a loss of bicarbonate (normal anion gap). 3. A patient is admitted following a traumatic brain injury (TBI). Which objective laboratory parameter is considered the definitive diagnostic test to continuously monitor the patient’s precise systemic oxygenation and ventilation status?
hostile, chronically irritating environment (e.g., ciliated columnar epithelial cells changing to stratified squamous cells in the airways of chronic smokers).
5. Which core phase of pharmacokinetics describes the systemic biotransformation or chemical alteration of a drug molecule, occurring primarily via hepatic enzyme pathways? A. Absorption B. Distribution C. Metabolism D. Excretion Answer: C Rationale: Metabolism (or biotransformation) is the enzymatic modification of a drug's chemical structure. This process takes place primarily in the liver via the cytochrome P450 enzyme system, preparing the drug molecule for ultimate elimination from the body. 6. A patient presents to the emergency department with profound diabetic ketoacidosis (DKA). The nurse anticipates an order for an intravenous insulin infusion. What is the primary therapeutic mechanism of insulin in treating this type of metabolic acidosis? A. It acts as a direct chemical buffer to neutralize circulating hydrogen ions.
B. It forces the kidneys to rapidly excrete excess metabolic acids. C. It shifts glucose into cells, halting fat breakdown and the production of acidic ketones. D. It stimulates the respiratory center to increase the depth of respirations. Answer: C Rationale: In DKA, a lack of insulin prevents cells from utilizing glucose for energy, forcing the body to break down fats instead. This breakdown produces highly acidic ketone bodies, leading to metabolic acidosis. Administering insulin allows glucose into the cells, stopping further lipolysis and ketone production.
7. A long-standing, unmanaged hypertensive patient shows marked enlargement of the left ventricle on an echocardiogram. At the cellular level, this structural change is best classified as which of the following? A. Pathologic hypertrophy B. Physiologic hypertrophy C. Pathologic hyperplasia D. Compensatory dysplasia Answer: A Rationale: Left ventricular enlargement in response to chronic hypertension represents pathologic hypertrophy. The individual cardiac muscle cells grow larger in
C. Anaplasia D. Hypertrophy Answer: B Rationale: Dysplasia is characterized by abnormal changes in cell size, shape, and organization. While it is an adaptive process that can be reversible if the stimulus is removed, it is strongly considered a precursor to malignant neoplastic transformation.
10. Which primary pharmacokinetic factor determines the rate and extent to which a drug molecule successfully moves from its initial site of administration into the circulating bloodstream? A. Bioavailability B. Absorption C. Distribution D. Clearance Answer: B Rationale: Absorption is defined specifically as the movement of a drug from its site of administration into the blood. The speed and efficiency of this process dictate how quickly a therapeutic effect will begin. 11. A client with chronic kidney disease presents with a serum potassium level of 6.2 mEq/L. Which pathophysiological mechanism explains why the heart
muscle is highly sensitive to this specific electrolyte imbalance? A. Hyperkalemia decreases the threshold potential, causing myocardial paralysis. B. Hyperkalemia alters the resting membrane potential, increasing cardiac cell excitability. C. Hyperkalemia accelerates the sodium-potassium pump, depleting intracellular calcium. D. Hyperkalemia blocks beta-adrenergic receptors, causing severe sinus tachycardia. Answer: B Rationale: Potassium is the primary intracellular cation and is a major determinant of the resting membrane potential (RMP). Elevated extracellular potassium (hyperkalemia) hypopolarizes the cell membrane, bringing the RMP closer to the threshold potential, which initially increases excitability and can lead to lethal cardiac arrhythmias.
12. A patient is prescribed a highly protein-bound medication. If the patient has severe malnutrition and low serum albumin levels, how will the drug's pharmacological profile be altered? A. The active drug effect will decrease because there are fewer protein carriers. B. The level of free, active drug will increase, significantly
that the respiratory system has not yet initiated a compensatory response. Therefore, it is uncompensated metabolic alkalosis.
14. Which cellular response occurs when a tissue experiences a prolonged lack of oxygen (hypoxia), leading to a rapid decline in intracellular ATP production? A. The cell swells due to a failure of the sodium-potassium ATPase pump. B. The cell shrinks because extracellular water rushes out to balance sodium. C. Intracellular pH rises sharply, causing enzymatic destruction of the nucleus. D. Calcium ions are actively forced out of the cell into the interstitial space. Answer: A Rationale: When ATP production drops due to hypoxia, the energy-dependent sodium-potassium (Na+/K+) ATPase pump fails. Sodium accumulates inside the cell, creating an osmotic gradient that draws water into the cytoplasm, resulting in acute cellular swelling. 15. A physician orders a loading dose of an intravenous antibiotic for a patient with a severe systemic infection. What is the primary pharmacological rationale for administering a loading dose?
A. To minimize the occurrence of adverse drug reactions and hypersensitivities. B. To completely bypass the liver's first-pass metabolic clearance pathways. C. To rapidly achieve a therapeutic drug concentration (steady state) in the plasma. D. To ensure the drug can cross the blood-brain barrier via passive diffusion. Answer: C Rationale: A loading dose is a large initial dose given to rapidly achieve a therapeutic plasma concentration or steady state. This approach is used when a drug has a long half-life but immediate therapeutic effects are required to treat an acute condition.
16. A patient is experiencing severe, prolonged diarrhea. Which acid-base imbalance is this patient at highest risk for developing? A. Metabolic Alkalosis B. Metabolic Acidosis C. Respiratory Acidosis D. Respiratory Alkalosis Answer: B Rationale: Pancreatic and intestinal secretions are highly alkaline because they contain high concentrations of bicarbonate (HCO3-). Prolonged diarrhea causes a
A. Hypertrophy B. Hyperplasia C. Metaplasia D. Dysplasia Answer: B Rationale: Hyperplasia is defined as an increase in the number of cells within an organ or tissue layer, resulting from an increased rate of cellular division. It can be physiologic (e.g., estrogen-stimulated growth of the endometrium) or pathologic.
19. A patient is diagnosed with an advanced malignant tumor. The nurse understands that "anaplasia" is a hallmark feature of cancer cells. Anaplasia is defined as: A. The rapid division of well-differentiated cells. B. A lack of cellular differentiation and a loss of structural specialization. C. The movement of cells from one localized tissue to a distant organ. D. The physiologic death of aged cells via programmed suicide pathways. Answer: B Rationale: Anaplasia refers to a total lack of cellular differentiation and structural organization. Anaplastic cells lose the specialized functional characteristics of
their tissue of origin, which is a classic hallmark of malignant, aggressive tumors.
20. The nurse adminsters a drug with a narrow therapeutic index (TI). Which clinical intervention is mandatory when managing a patient on this type of medication? A. Assessing the patient's dynamic vital signs every 15 minutes indefinitely. B. Regularly monitoring serum drug levels via peak and trough draws. C. Changing the route of administration to oral as quickly as possible. D. Restricting all dietary intake of fat and protein during the treatment course. Answer: B Rationale: A narrow therapeutic index means that the margin of safety between a therapeutic dose and a toxic dose is very small. Regular monitoring of plasma or serum drug levels (peaks and troughs) is necessary to ensure the drug remains within the therapeutic range without causing toxicity. 21. A patient with chronic obstructive pulmonary disease (COPD) has a blood gas showing a chronically elevated PaCO2. Which physiological compensation mechanism does the body employ to stabilize the pH?
Answer: C Rationale: Agonists are molecules that bind to cellular receptors and activate them, mimicking the physiological effects of endogenous regulatory hormones, neurotransmitters, or local mediators.
23. A patient experiences severe cell injury due to exposure to toxic heavy metals. The cells undergo unregulated, chaotic enzymatic digestion, leading to membrane rupture and the release of inflammatory contents into the surrounding tissue. This process is called: A. Apoptosis B. Necrosis C. Autophagy D. Senescence Answer: B Rationale: Necrosis is pathologic cellular death resulting from severe, irreversible injury. It involves cell swelling, membrane rupture, and the uncontained release of intracellular contents into surrounding tissues, which triggers an inflammatory response. This contrasts with apoptosis, which is programmed and non-inflammatory. 24. Which parameter represents the time required for the total amount of a drug in the body to decrease by exactly 50% during the elimination phase?
A. Clearance rate B. Volume of distribution C. Drug half-life (t1/2) D. Bioavailability window Answer: C Rationale: The elimination half-life (t1/2) is the time required for the plasma concentration of a drug to decrease by 50%. This constant value helps determine dosing intervals and the time needed to reach a steady- state concentration.
25. A patient's laboratory values reveal a serum sodium level of 118 mEq/L. Which pathophysiological consequence should the nurse monitor for most closely? A. Intracellular dehydration and cellular shrinking in the skeletal muscles. B. Severe cellular swelling and cerebral edema within the central nervous system. C. Increased myocardial contractility leading to profound hypertension. D. Direct suppression of the bone marrow's red blood cell production. Answer: B Rationale: Severe hyponatremia (sodium < 120 mEq/L) creates a hypotonic extracellular environment. Water moves out of the vasculature and into cells along an
C. Efficacy measures how tightly a drug binds to a receptor, while potency is the drug's half-life. D. Potency is the drug's ability to cross the blood-brain barrier, while efficacy is its excretion rate. Answer: A Rationale: Efficacy refers to the maximal therapeutic response an index drug can achieve, regardless of dose. Potency refers to the dose or concentration of a drug required to produce a specific effect of a given intensity; a more potent drug requires a smaller dose to achieve the same effect.
28. A patient has an arterial blood gas showing: pH 7.51, PaCO2 28 mmHg, and HCO3 24 mEq/L. Which clinical condition is most likely to cause this specific acid-base imbalance? A. Acute exacerbation of severe asthma with air trapping B. An intense panic attack with profound hyperventilation C. Chronic renal failure with loss of erythropoietin production D. Prolonged nasogastric suctioning removing stomach acid Answer: B Rationale: The pH is elevated (7.51), indicating alkalosis. The PaCO2 is low (28 mmHg), indicating excessive excretion of carbon dioxide through hyperventilation. The HCO3 is normal, confirming that this is an uncompensated respiratory alkalosis. An intense panic
attack causes hyperventilation, which drives down PaCO2 and raises pH.
29. The process by which a drug translocates through systemic fluids and tissues to reach its specific targeted site of physiological action is defined as: A. Biotransformation B. Absorption C. Distribution D. Clearance Answer: C Rationale: Distribution is the pharmacokinetic process describing the transport of a drug throughout the body's various fluid compartments and tissues after it has entered the systemic bloodstream. 30. During ischemic cell injury, an influx of which intracellular ion serves as a final common pathway for cell irreversible injury and death by activating destructive catabolic enzymes? A. Sodium B. Potassium C. Calcium D. Magnesium Answer: C Rationale: Ischemia causes cell membrane damage and
